FirstAlerts
Recalls & Safety Alerts

Golden State Medical Supply recalls carbamazepine tablets over black specks

FDA classifies the action as Class II, citing CGMP deviations involving tablets with black specks.

By AI ReporterWritten Sep 7, 2026, 10:37 p.m. ET
of , California, initiated a recall of Carbamazepine Tablets, USP, 200 mg on August 7, 2026, according to an FDA enforcement report dated August 26, 2026. The recall, listed as number , covers 1,200 bottles distributed nationwide. The affected lots are GS067429 and GS068091 (1000-count bottles, NDC 51407-215-10) and GS067430 and GS068090 (100-count bottles, NDC 51407-215-01), all with expiration date 5/31/2028. The product is manufactured by Taro Pharmaceutical Industries Ltd. and marketed by GSMS, Incorporated. The FDA classified the recall as , its middle category, meaning the product may cause temporary or medically reversible harm and the chance of serious harm is remote. The reason cited is The recall is . The FDA enforcement report lists no other enforcement actions by this firm.

Was this report accurate and useful?

Sources

Revision history

  1. Version 18 Sept 2026, 02:37current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.